Table 2 Patient outcomes
From: Three-years outcomes of diabetic patients treated with coronary bioresorbable scaffolds
Within 30 Days | Between 31 Days and 1 year | After 1 year | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
All | Diab | No Diab | P | HR [95% CI] | All | Diab | No Diab | P | HR [95% CI] | All | Diab | No Diab | p | HR [95% CI] | |
All Death | 12 (1.9%) | 2 (1.5%) | 10 (2.0%) | 0.713 | 0.75 [0.19–3.02] | 7 (1.2%) | 1 (0.8%) | 6 (1.3%) | 0.666 | 0.63 [0.10–3.89] | 24 (5.2%) | 8 (7.7%) | 16 (4.5%) | 0.129 | 1.91 [0.71–5.11] |
CV Death | 7 (1.1%) | 2 (1.5%) | 5 (1.0%) | 0.623 | 1.50 [0.24–9.26] | 5 (0.8%) | 0 | 5 (1.0%) | 0.250 | – | 12 (2.5%) | 7 (6.9%) | 5 (1.4%) | 0.001 | 5.37 [1.33–21.71] |
Any MI | 12 (1.9%) | 4 (3.0%) | 8 (1.6%) | 0.286 | 1.90 [0.47–7.64] | 16 (2.7%) | 4 (3.3%) | 12 (2.6%) | 0.661 | 1.29 [0.38–4.32] | 25 (5.5%) | 6 (6.4%) | 19 (5.3%) | 0.705 | 1.19 [0.46–3.13] |
Target Vessel MI | 10 (1.6%) | 3 (2.2%) | 7 (1.4%) | 0.477 | 1.62 [0.35–7.46] | 12 (2.0%) | 4 (3.3%) | 8 (1.7%) | 0.275 | 1.93 [0.48–7.81] | 15 (2.8%) | 3 (2.6%) | 12 (2.8%) | 0.928 | 0.94 [0.27–3.27] |
ScR | – | – | – | – | – | 13 (2.2%) | 5 (4.0%) | 8 (1.7%) | 0.116 | 2.38 [0.62–9.09] | 28 (10.3%) | 13 (17.6%) | 15 (7.8%) | < 0.001 | 3.56 [1.40–9.05] |
ScT | 14 (2.2%) | 3 (2.2%) | 11 (2.2%) | 0.963 | 1.03 [0.28–3.73] | 5 (0.9%) | 0 | 5 (1.1%) | 0.251 | – | 9 (1.7%) | 1 (1.4%) | 8 (1.8%) | 0.459 | 0.46 [0.09–2.30] |
TLR | – | – | – | – | – | 22 (3.7%) | 6 (4.9%) | 16 (3.4%) | 0.443 | 1.44 [0.51–4.04] | 33 (11.5%) | 12 (17.0%) | 21 (9.5%) | 0.016 | 2.32 [0.98–5.47] |